Akoya Biosciences Inc (AKYA)
2.37
-0.76
(-24.28%)
USD |
NASDAQ |
Nov 15, 10:57
Akoya Biosciences Cash from Operations (Quarterly): -11.04M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -11.04M |
| March 31, 2024 | -20.82M |
| December 31, 2023 | -5.584M |
| September 30, 2023 | -13.75M |
| June 30, 2023 | -11.80M |
| March 31, 2023 | -19.76M |
| December 31, 2022 | -10.01M |
| September 30, 2022 | -12.17M |
| June 30, 2022 | -13.39M |
| Date | Value |
|---|---|
| March 31, 2022 | -17.93M |
| December 31, 2021 | -5.854M |
| September 30, 2021 | -13.40M |
| June 30, 2021 | -12.42M |
| March 31, 2021 | -4.404M |
| December 31, 2020 | -2.147M |
| September 30, 2020 | -1.74M |
| June 30, 2020 | -1.999M |
| March 31, 2020 | -0.957M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-20.82M
Minimum
Mar 2024
-0.957M
Maximum
Mar 2020
-9.954M
Average
-11.42M
Median
Cash from Operations (Quarterly) Benchmarks
| Bruker Corp | 38.40M |
| Azenta Inc | 1.791M |
| Harvard Bioscience Inc | -0.842M |
| Bionano Genomics Inc | -20.98M |
| Singular Genomics Systems Inc | -18.04M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 9.054M |
| Cash from Financing (Quarterly) | -2.125M |
| Free Cash Flow | -53.61M |
| Free Cash Flow Per Share (Quarterly) | -0.2269 |
| Free Cash Flow to Equity (Quarterly) | -11.43M |
| Free Cash Flow to Firm (Quarterly) | -9.266M |
| Free Cash Flow Yield | -45.87% |